Vergoeding 2020-2024 voor ATC-subgroep A10BD : Combinaties van bloedglucoseverlagende middelen
- Raming voor de totale Zvw-populatie
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| A10BD02 Metformine met sulfonylureumderivaten (Glucovance ®) | 18.142 | 21.222 | 17.655 | 10.368 | 10.702 |
| A10BD05 Metformine met pioglitazon | 21.987 | 18.048 | 21.045 | 18.628 | 16.216 |
| A10BD07 Metformine met sitagliptine (Janumet ®) | 1.763.400 | 1.722.900 | 1.672.300 | 1.355.900 | 1.001.000 |
| A10BD08 Metformine met vildagliptine (Eucreas ®) | 1.455.700 | 1.363.100 | 1.327.400 | 1.001.000 | 779.610 |
| A10BD11 Metformine met linagliptine (Jentadueto ®) | 94.612 | 101.310 | 106.240 | 111.940 | 113.880 |
| A10BD15 Metformine met dapagliflozine (Xigduo ®) | 121.680 | 132.010 | 175.830 | 228.960 | 270.390 |
| A10BD20 Metformine met empagliflozine (Synjardy ®) | 154.390 | 160.070 | 224.330 | 273.920 | 292.450 |
| A10BD23 Metformine met ertugliflozine | 349 | 21 | . | . | . |
| Totaal | 3.630.260 | 3.518.681 | 3.544.800 | 3.000.716 | 2.484.248 |